Plain-English translation of NCT06989580 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Heart Failure research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial tests a small heart monitoring device called BIOMONITOR that sits under your skin and continuously watches your heart's rhythm and function. Researchers want to use the data from this device to develop better ways to predict when heart failure might get worse and to catch irregular heartbeats earlier, so doctors can help you before problems become serious.
Many people with heart failure have sudden flare-ups that require emergency care or hospitalization. This trial aims to find new ways to predict these dangerous episodes in advance using continuous heart monitoring, so treatment can be adjusted earlier and prevent crises.
You likely qualify if…
You likely don't qualify if…
You will receive the BIOMONITOR device, which is implanted under your skin in a minor outpatient procedure. The device continuously monitors your heart rhythm and collects data about your heart function. You will attend follow-up visits at the study site and also use the device's home monitoring system (CardioMessenger) to share data with your care team. The study follows your progress over time to help researchers understand how the device data can predict and prevent heart failure flare-ups.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
Belgium
Germany